Innovation, Access Issues Dominate Biologics & Biosimilars Summit
“I thought maybe I wasn’t very good athletically.” That was iconic Olympic gold medalist Jackie Joyner-Kersee’s recollection of her first experience with asthma attacks.
Cost Sharing is Costing Skin Patients their Medication
After spending time and money to see a dermatologist, many patients with acne fail to fill their prescription. Cost sharing is the culprit, according to a recently published study.
FDA Opens Door to Pregnant Women in Clinical Trials
Nearly 4 million babies are born each year in the United States. Yet physicians can have remarkably limited data about treating mothers’ health conditions during pregnancy.
Patents, Progress & Patient Access
Could a recent memorandum from the U.S. Patent and Trademark Office impact treatment options for patients? Washington, DC’s nonprofit Bipartisan Policy Center says: Yes.
“The ICER Myth” Questions One-Size-Fits-All Approach to Drug Valuation
What is innovative medicine worth to patients? It depends on which patient you ask. The disease a patient suffers from, its symptoms and their impact on a patient’s day-to-day life make the question a highly personal one. So does the extent to which a medicine addresses symptoms or even cures a disease.
What Your Pharmacist Can’t Tell You
Patients overpay for their prescriptions 23 percent of the time, a recently released study from the University of Southern California found. What’s worse – some pharmacists can’t tell patients when they’re paying too much.
Mapping Report Reveals Access Disparities among European Patients
How accessible is your health care? It all depends upon where you live, as a new report from the European Federation of Crohn’s & Ulcerative Colitis Associations confirms.
The FDA Invitation that Patient Advocates are Awaiting
Open dialogue is an important part of the drug approval process.
ICER Report Dampens Prospects for Cystic Fibrosis Treatment
If health plans heed a new report from the Institute for Clinical and Economic Review, patients with few options to treat their cystic fibrosis may soon have fewer still.
What Medicare’s Opioid Policy Left Out
More than 1,000 people per day receive treatment in emergency rooms across the country for misusing prescription opioids. And approximately 115 Americans die daily from opioid overdose.
